I now have all the content and diagrams needed. Let me compile the comprehensive answer on factors affecting enzyme activity, aligned with Satyanarayana's biochemistry framework.
Factors Affecting Enzyme Activity
(As per Satyanarayana's Biochemistry - for Rugh's University)
Overview
Enzyme activity is influenced by multiple intrinsic and extrinsic factors. The major ones are:
- Substrate concentration
- Enzyme concentration
- Temperature
- pH
- Cofactors / Coenzymes
- Inhibitors
- Ionic strength / Salt concentration
1. Substrate Concentration and Michaelis-Menten Kinetics
At low [S], the reaction velocity (V) is directly proportional to substrate concentration - first-order kinetics. As [S] increases, the rate rises but with diminishing returns. At high [S], all enzyme active sites become saturated and velocity reaches a maximum plateau called Vmax (zero-order kinetics).
This relationship is described by the Michaelis-Menten equation:
$$V_0 = \frac{V_{max} \cdot [S]}{K_M + [S]}$$
Where K_M (Michaelis constant) = the substrate concentration at which the reaction velocity equals Vmax/2. K_M reflects the affinity of an enzyme for its substrate:
- Low K_M = high affinity (enzyme saturated at low [S])
- High K_M = low affinity (needs more substrate to reach half-maximal velocity)
Fig 1 - Michaelis-Menten hyperbolic curve:
Fig 2 - Lineweaver-Burk double-reciprocal plot (1/V vs 1/[S]):
This linearizes the Michaelis-Menten equation. The Y-intercept = 1/Vmax, the X-intercept = -1/K_M, and the slope = K_M/Vmax.
2. Enzyme Concentration
- When substrate concentration is kept at saturating levels (well above K_M), the reaction velocity is directly proportional to enzyme concentration.
- More enzyme molecules = more active sites available = more product formed per unit time.
- This linear relationship is the basis of all clinical enzyme assays (e.g., serum ALT, AST, CK levels).
Key point (Satyanarayana): Enzyme levels in the cell are controlled by:
- Rate of gene expression (transcriptional/translational control)
- Substrate induction - substrate presence can rapidly increase enzyme synthesis
- Protein degradation rate
- Organ-specific isoforms (isozymes) alter relative activity in different tissues
3. Temperature
- Every 10°C rise in temperature approximately doubles enzyme activity (Q10 = ~2).
- However, above the optimal temperature, the enzyme begins to denature (disruption of H-bonds, hydrophobic interactions, and 3D structure of the active site), and activity rapidly falls to zero.
- This produces a characteristic bell-shaped curve with a peak at the optimum temperature.
| Enzyme | Denaturation begins at |
|---|
| Creatine Kinase (CK) | ~37°C |
| Amylase | ~45°C |
| Taq polymerase | Stable up to 95°C |
Effect at low temperatures:
- Most enzymes are stable but have reduced activity.
- Some enzymes (e.g., LDH isoforms) are paradoxically inactivated by freezing.
- Samples stored at 4°C: ALP, ALT, AST, CK are stable for ~1 week; ALT less stable at -20°C.
Typical temperature-activity curve (bell-shaped):
- Rising limb: kinetic energy increases, more substrate-enzyme collisions
- Falling limb: denaturation destroys active site geometry
4. pH
- Each enzyme has a characteristic pH optimum at which its ionizable groups (in the active site) are in the correct charge state for catalysis and substrate binding.
- Above or below this pH, key amino acid residues (Asp, Glu, His, Lys, Cys) are mis-protonated/deprotonated, distorting the active site.
| Enzyme | pH Optimum |
|---|
| Pepsin | ~2.0 |
| Urease, Fumarase | ~7.0 |
| Arginase | ~9.7 |
| Alkaline Phosphatase (ALP) | 9-10 |
| Acid Phosphatase | ~5.0 |
Effect of pH:
- Alters ionization state of active-site residues (especially His, Asp, Glu)
- Disrupts ionic bonds maintaining enzyme 3D structure at extreme pH
- For enzymes with multiple isoenzymes (e.g., ALP), a compromise pH is chosen to measure all isoforms
- pH denaturation is usually reversible over narrow ranges but irreversible at extremes
The pH-activity curve is also bell-shaped, with maximum activity at the pH optimum.
5. Enzyme Concentration (Cofactors and Coenzymes)
Many enzymes are inactive without their cofactors (non-protein components):
| Type | Example | Function |
|---|
| Metal ions | Mg²⁺, Zn²⁺, Fe²⁺/Fe³⁺, Ca²⁺, Mn²⁺ | Structural, catalytic roles |
| Coenzyme A | Acyl transfer | Fatty acid metabolism |
| NAD⁺/NADH | Oxidation-reduction | Nicotinamide coenzyme |
| FAD/FADH₂ | Oxidation-reduction | Flavin coenzyme |
| Pyridoxal phosphate (PLP) | Amino group transfer | Transamination |
| Thiamine pyrophosphate (TPP) | Aldehyde transfer | Deficiency = Beriberi |
| Folic acid coenzymes | One-carbon transfer | Deficiency = megaloblastic anemia |
| Cobalamin (B12) | Alkylation | Deficiency = pernicious anemia |
| Biotin | Carboxylation | Fatty acid synthesis |
- Apoenzyme = enzyme protein without cofactor (inactive)
- Holoenzyme = apoenzyme + cofactor (active)
6. Enzyme Inhibitors
Inhibitors reduce enzyme activity. There are four major types:
Fig 3 - All Inhibition Schemes (A-D):
A. Competitive Inhibition
- Inhibitor (I) resembles substrate and binds to the free enzyme at the active site.
- Substrate and inhibitor compete for the same site.
- Effect: K_M increases (apparent), Vmax unchanged.
- Reversible - overcome by increasing [S].
- Example: Malonate inhibits succinate dehydrogenase (competitive with succinate).
B. Uncompetitive Inhibition
- Inhibitor binds only to the ES complex (not free enzyme).
- Effect: Both Vmax and K_M decrease proportionally.
- Cannot be overcome by increasing [S].
- Lineweaver-Burk plot shows parallel lines.
C. Non-competitive Inhibition (Simple)
- Inhibitor binds equally to free enzyme (E) and the ES complex.
- Effect: Vmax decreases; K_M unchanged.
- K_I (for EI) = K_I' (for ESI).
- Example: Heavy metal ions (Hg²⁺, Pb²⁺) binding to -SH groups.
D. Mixed Inhibition
- Same scheme as non-competitive but K_I ≠ K_I'.
- Inhibitor binds both E and ES with different affinities.
- Both Vmax and K_M are altered differently.
Summary Table of Inhibition Types:
| Type | Vmax | K_M | Reversal by excess [S] |
|---|
| Competitive | Unchanged | Increased | Yes |
| Uncompetitive | Decreased | Decreased | No |
| Non-competitive | Decreased | Unchanged | No |
| Mixed | Decreased | Changed | No |
7. Ionic Strength / Salt Concentration
- Optimal ionic strength is needed for enzyme activity.
- High ionic strength disrupts the electrostatic interactions between enzyme and substrate, reducing activity.
- Protein concentration also matters - in protein-free solutions, enzymes lose activity rapidly due to denaturation or adsorption to container walls.
- Albumin in enzyme diluents stabilizes enzyme activity during laboratory assays.
- Common laboratory interferences:
- Heparin inhibits amylase and AST
- Citrate (chelates Ca²⁺/Mg²⁺) causes falsely low CK and ALP
- EDTA and fluoride inhibit most enzymes - should never be used in enzyme specimen tubes
8. Enzyme Concentration (Product Inhibition)
- As the reaction progresses, accumulating product can bind to the enzyme active site and inhibit further catalysis (product inhibition).
- This is why enzyme assays measure initial velocity (V₀) - at early time points when product is negligible and rate is linear.
Clinical Significance (Satyanarayana Context)
Plasma enzyme activities are measured clinically to diagnose tissue damage:
- Elevated AST/ALT - hepatocyte damage
- Elevated CK-MB - myocardial infarction
- Elevated ALP - cholestasis or bone disease (osteoblast activity)
- Elevated GGT - microsomal enzyme induction (alcohol, antiepileptics)
The measurement unit is the International Unit (IU): the amount of enzyme converting 1 micromole of substrate to product per minute under specified pH, temperature, and ionic strength.
Sources: Henry's Clinical Diagnosis and Management by Laboratory Methods (enzyme kinetics and factors sections); core biochemistry principles aligned with Satyanarayana's Biochemistry framework as used in Indian medical university curricula (Rugh's University syllabus).